欢迎来到360期刊网!
学术期刊
  • 学术期刊
  • 文献
  • 百科
电话

您当前的位置:    首页  >  SCI投稿 > JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY税费

Radiation Exposure in Pediatric Sarcoma Patients Receiving Initial Curative Chemotherapy.

切换为中文

Abstract:

:The objective of our study is to estimate the radiation exposure to pediatric patients with sarcoma getting required (or highly recommended) ionizing radiation scans during initial chemotherapy and to determine how often distant progressive disease was discovered. Data from the last 25 years from the Children's Oncology Group open phase III protocols were reviewed for the most common pediatric sarcomas: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. The number of required/recommended ionizing radiation scans, including chest radiographs, chest computed tomography, positron emission tomography scans, and bone scans during induction, consolidation, and maintenance chemotherapy, were recorded and the total radiation dose per patient was calculated. In addition, the number of patients who were removed from protocol during chemotherapy because of new or distant progressive disease was documented. In our analysis of 5845 patients, the average pediatric patient with sarcoma on protocol was exposed to an ionizing radiation dose of 37.1 mGy, equivalent to the lifetime dose of nuclear power plant workers, whereas the progression of disease was detected at most in 5.4% of the patients. Our study is meant to inform pediatric oncologists more precisely of the actual risks and benefits of mandated surveillance scans during chemotherapy in patients with sarcoma.

展开更多

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

J PEDIAT HEMATOL ONC
最新影响因子:1.016 期刊ISSN:1077-4114 CiteScore:
出版周期:Bimonthly 是否OA:YES 出版年份:1995

期刊官方网址:http://journals.lww.com/jpho-online/pages/default.aspx

期刊投稿地址:http://www.editorialmanager.com/jpho/default.aspx

自引率:5.00% 研究方向:医学-小儿科
出版地区:UNITED STATES

SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)

NCBI查询:PubMed Central (PMC)链接全文检索(pubmed central)

专业编辑在线一对一答疑及时解决您的问题

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 期刊简介

英文简介:

Published by Lippincott Williams and Wilkins. ISSN: 1077-4114. The Journal of Pediatric Hematology / Oncology reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. Each bimonthly issue presents informative case studies and original research articles from leading clinicians and investigators worldwide. Also featured are specially developed Continuing Seminars, which serve the continuing education needs of physicians by offering new insights into many areas of interest, as well as analyses of radiological problems in pediatric hematology / oncology and discussions of pertinent ethical and legal issues.

中文简介:(来自Google、百度翻译)

由Lippincott Williams和Wilkins出版。ISSN: 1077 - 4114。 《儿科血液学/肿瘤学杂志》报告了在儿童癌症和血液疾病的诊断和治疗方面的重大进展。每一期双月刊提供来自世界领先临床医生和研究人员的有价值的案例研究和原创研究文章。专题还包括专门开发的持续研讨会,通过对许多感兴趣的领域提供新的见解,分析儿科血液学/肿瘤学中的放射学问题,讨论相关的伦理和法律问题,从而满足医生的继续教育需求。

申请加急绿色通道,投稿周期比同行快2-3个月 现在咨询

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 期刊中科院评价数据

最新中科院分区

大类(学科) 小类(学科) 学科排名
医学 HEMATOLOGY(血液学) 4区
ONCOLOGY(肿瘤学) 4区
PEDIATRICS(儿科学) 4区
65/71
213/223
98/124

最新公布的期刊年发文量

年度总发文量 年度论文发表量 年度综述发表量
242 224 18
总被引频次:3658
特征因子:0.005040

影响因子趋势图

无法辨别期刊质量?专业编辑老师一对一讲解,现在咨询现在咨询

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 期刊CiteScore评价数据

最新CiteScore值

=

引文计数(2018)

文献(2015-2017)

=

次引用

篇文献

文献总数(2014-2016):
被引比率:%
SJR:
SCLmago期刊等级衡量经过加权后的期刊受引用次数,引用次数的加权值由施引期刊的学科领域和声望(SJR)决定。
SNIP:
每篇文章中来源出版物的标准化影响将实际受引用情况对照期刊所属学科领域中预期的受引用情况进行衡量。

CiteScore排名

序号 类别 排名 百分位

CiteScore趋势图

Scopus涵盖范围

无法辨别期刊质量?专业编辑老师一对一讲解,现在咨询现在咨询

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 期刊常见问题

热门常见问题

无法辨别期刊质量?专业编辑老师一对一讲解,现在咨询现在咨询

权益保障

  • 刊物信息可查
    刊物信息可查

    推荐刊物均可到国家新闻出
    版总署网站查询正刊

  • 严格保密协协议
    严格保密协协议

    可签署保密协议 ,不透露任
    何用户信息可跟踪进程,全程
    协议

  • 售后服务保障
    售后服务保障

    1对1服务,7x24小时在线

  • 企业信誉保障
    企业信誉保障

    11年经验沉淀,实体公司
    运营

品牌运营 , 成功助力数万用户

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 投稿经验

(由下方点评分析获得,2人参与,1156人阅读)

  • 偏重的研究方向:
  • 投稿录用比例:
    暂无
  • 审稿速度:
    平均3个月的审稿周期(非官方数据)

最新评论(不代表本站观点)

  • avatar

    liting7111

    接受率: 比较困难(25%命中)

    投稿后,一审意见主要是觉得细胞株只有一个太少了,花了三个月时间按照要求多做了一个,审稿两个月结果拒稿了!理由是接收率只有25%,你倒是在一审的时候就给我拒稿了啊!
    2020-01-18
  • avatar

    liting7111

    研究方向:儿童血液

    审稿时间: 3个月内 接受率: 比较困难(25%命中)

    审稿比较慢,一审等了三个月才给意见,大修,投回去几周才通知拒稿。问过其他投过这本的,都说审稿周期长!
    2019-05-23

相关期刊

360期刊网

专注医学期刊服务11年

客服正在输入...

  • 我是360期刊网在线指导老师,请问您想咨询什么等级的期刊(省级、国家级、核心、SCI)?我们提供以下服务:

  • 1.学术期刊服务
    2.SCI期刊服务
    3.论文指导服务

  • 现在咨询抢0元论文评估名额

x
立即咨询